Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $28,272 | 1 | 60.0% |
| Consulting Fee | $15,276 | 19 | 32.4% |
| Food and Beverage | $1,878 | 72 | 4.0% |
| Travel and Lodging | $1,050 | 5 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $450.00 | 1 | 1.0% |
| Education | $207.11 | 2 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Becton, Dickinson and Company | $28,272 | 1 | $0 (2018) |
| Spiration, Inc. | $10,778 | 15 | $0 (2019) |
| Covidien LP | $3,145 | 8 | $0 (2017) |
| Gyrus ACMI, Inc. | $1,800 | 3 | $0 (2022) |
| Auris Health, Inc. | $1,248 | 10 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $463.99 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $247.08 | 13 | $0 (2020) |
| Lilly USA, LLC | $205.80 | 8 | $0 (2020) |
| Ethicon Inc. | $202.08 | 3 | $0 (2019) |
| Genentech USA, Inc. | $146.29 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $525.00 | 1 | Gyrus ACMI, Inc. ($525.00) |
| 2021 | $450.00 | 1 | Gyrus ACMI, Inc. ($450.00) |
| 2020 | $883.05 | 4 | Gyrus ACMI, Inc. ($825.00) |
| 2019 | $1,625 | 27 | Spiration, Inc. ($750.00) |
| 2018 | $35,368 | 31 | Becton, Dickinson and Company ($28,272) |
| 2017 | $8,283 | 36 | Spiration, Inc. ($4,628) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/26/2022 | Gyrus ACMI, Inc. | Spiration Valve System (Device) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Endotherapy | ||||||
| 04/07/2021 | Gyrus ACMI, Inc. | Spiration Valve System (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Endotherapy | ||||||
| 09/02/2020 | Gyrus ACMI, Inc. | SVS (Device) | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| Category: EndoTherapy | ||||||
| 02/12/2020 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA, VERZENIO | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Oncology | ||||||
| 01/22/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Oncology | ||||||
| 12/20/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Oncology | ||||||
| 12/05/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Oncology | ||||||
| 12/02/2019 | Genentech USA, Inc. | Rituxan (Biological), GAZYVA, VENCLEXTA | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: BioOncology/Immunology | ||||||
| 11/20/2019 | Seattle Genetics, Inc. | — | Food and Beverage | In-kind items and services | $14.25 | General |
| 10/31/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Oncology | ||||||
| 10/01/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: BioOncology | ||||||
| 08/21/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2019 | Ethicon Inc. | NEUWAVE Flex Microwave Ablation System (Device) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Ablation System | ||||||
| 07/30/2019 | Spiration, Inc. | Olympus Respiratory Accessories (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: GI & Respiratory Products | ||||||
| 06/21/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2019 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), SANDOSTATIN | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2019 | Ethicon Inc. | MONARCH (Device) | Food and Beverage | In-kind items and services | $86.57 | General |
| Category: ENDO-MECHANICAL | ||||||
| 06/12/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2019 | Ethicon Inc. | MONARCH (Device) | Travel and Lodging | In-kind items and services | $95.00 | General |
| Category: ENDO-MECHANICAL | ||||||
| 05/23/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2019 | Janssen Biotech, Inc. | Balversa (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Oncology | ||||||
| 04/25/2019 | Array BioPharma Inc. | Braftovi (Drug), Mektovi | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Melanoma | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Swift | Becton, Dickinson and Company | $28,272 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 135 | 151 | $57,920 | $10,313 |
| 2020 | 13 | 574 | 688 | $410,482 | $43,849 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 60 | 71 | $27,477 | $4,925 | 17.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 46 | 50 | $12,550 | $2,289 | 18.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $10,795 | $1,804 | 16.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 12 | 13 | $7,098 | $1,294 | 18.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 171 | 251 | $97,137 | $14,691 | 15.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 101 | 127 | $69,342 | $10,643 | 15.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 72 | 72 | $45,720 | $6,954 | 15.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 23 | 23 | $19,044 | $3,034 | 15.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 55 | 60 | $15,060 | $2,251 | 15.0% |
| 31626 | Insertion of radiation therapy markers into lung airways using an endoscope | Facility | 2020 | 14 | 14 | $43,260 | $1,962 | 4.5% |
| 31628 | Biopsy of one lobe of lung using an endoscope | Facility | 2020 | 18 | 18 | $43,794 | $1,536 | 3.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2020 | 29 | 30 | $60,390 | $934.50 | 1.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 13 | 13 | $4,875 | $763.59 | 15.7% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Facility | 2020 | 12 | 12 | $2,988 | $471.30 | 15.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 22 | 23 | $3,082 | $233.68 | 7.6% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2020 | 22 | 22 | $3,168 | $211.64 | 6.7% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 22 | 23 | $2,622 | $163.99 | 6.3% |
About Dr. Daniel Nader, D.O
Dr. Daniel Nader, D.O is a Pulmonary Disease healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972564169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Nader, D.O has received a total of $47,133 in payments from pharmaceutical and medical device companies, with $525.00 received in 2022. These payments were reported across 100 transactions from 29 companies. The most common payment nature is "" ($28,272).
As a Medicare-enrolled provider, Nader has provided services to 709 Medicare beneficiaries, totaling 839 services with total Medicare billing of $54,162. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Tulsa, OK
- Active Since 03/29/2006
- Last Updated 07/09/2008
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1972564169
Products in Payments
- Spiration Valve System (Device) $11,003
- superDimension (Device) $3,113
- SVS (Device) $825.00
- Olympus Respiratory Accessories (Device) $750.00
- Monarch (Device) $280.97
- MONARCH (Device) $181.57
- CYRAMZA (Drug) $145.70
- TECENTRIQ (Biological) $114.53
- Photofrin (Drug) $111.48
- MEKINIST (Drug) $62.88
- ALIMTA (Drug) $60.10
- PROMACTA (Drug) $57.38
- Stivarga (Drug) $49.27
- KISQALI (Drug) $46.74
- OPDIVO (Biological) $45.62
- TASIGNA (Drug) $44.72
- Prolastin-C (Biological) $42.32
- INJECTAFER (Drug) $41.16
- Xofigo (Drug) $36.97
- Aranesp (Biological) $35.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Tulsa
Grace Kennedy, Do, DO
Pulmonary Disease — Payments: $51,016
Emil Schelbar, Md, MD
Pulmonary Disease — Payments: $20,986
Mr. Andrew Gottehrer, M.d, M.D
Pulmonary Disease — Payments: $18,122
Akhilesh Mahajan, Md, MD
Pulmonary Disease — Payments: $7,618
Dr. Eugene Quaye, D.o, D.O
Pulmonary Disease — Payments: $5,169
Dr. Roger Gallup, M.d, M.D
Pulmonary Disease — Payments: $4,309